Correlation Between Actinium Pharmaceuticals and Ibio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Actinium Pharmaceuticals and Ibio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Actinium Pharmaceuticals and Ibio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Actinium Pharmaceuticals and Ibio Inc, you can compare the effects of market volatilities on Actinium Pharmaceuticals and Ibio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Actinium Pharmaceuticals with a short position of Ibio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Actinium Pharmaceuticals and Ibio.

Diversification Opportunities for Actinium Pharmaceuticals and Ibio

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Actinium and Ibio is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Actinium Pharmaceuticals and Ibio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ibio Inc and Actinium Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Actinium Pharmaceuticals are associated (or correlated) with Ibio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ibio Inc has no effect on the direction of Actinium Pharmaceuticals i.e., Actinium Pharmaceuticals and Ibio go up and down completely randomly.

Pair Corralation between Actinium Pharmaceuticals and Ibio

Given the investment horizon of 90 days Actinium Pharmaceuticals is expected to under-perform the Ibio. But the stock apears to be less risky and, when comparing its historical volatility, Actinium Pharmaceuticals is 1.12 times less risky than Ibio. The stock trades about -0.26 of its potential returns per unit of risk. The Ibio Inc is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  280.00  in Ibio Inc on August 30, 2024 and sell it today you would lose (17.00) from holding Ibio Inc or give up 6.07% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Actinium Pharmaceuticals  vs.  Ibio Inc

 Performance 
       Timeline  
Actinium Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Actinium Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Ibio Inc 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ibio Inc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Ibio displayed solid returns over the last few months and may actually be approaching a breakup point.

Actinium Pharmaceuticals and Ibio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Actinium Pharmaceuticals and Ibio

The main advantage of trading using opposite Actinium Pharmaceuticals and Ibio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Actinium Pharmaceuticals position performs unexpectedly, Ibio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibio will offset losses from the drop in Ibio's long position.
The idea behind Actinium Pharmaceuticals and Ibio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world